Saudi Arabian Healthcare Market Forecast to 2012

Summary

Saudi Arabia is one of the most attractive destinations for healthcare professionals in the world. The sector has witnessed rapid advancements in terms of technology in past few years. Backed by these advancements, Saudi Arabian healthcare market is witnessing rapid growth and will continue expanding exponentially in future. Lifestyle diseases, such as obesity, diabetes and hypertension, in the country are amongst the highest in the world and thus, these are expected to significantly boost the country's healthcare spending in future. The healthcare sector in Saudi Arabia seems very promising and is expected to outpace the growth rate of other countries in the Middle East region in coming times.

Our new research report Saudi Arabian Healthcare Market Forecast to 2012 says that the healthcare sector in Saudi Arabia is expected to enjoy a double-digit growth in future. The pharmaceutical market and medical device market in Saudi Arabia are forecasted to grow at a CAGR of around 12% and 7% respectively. Currently, the market is characterized by huge private investments and this trend is likely to continue in near future also.

Our report has found that healthcare market is expected to grow more strongly as the government is spending heavily in the sector. Increasing prevalence of chronic disease and ageing population are also expected to support the growth of the sector. However, there are several factors, like high cost of healthcare treatments in the country, economic dependency of the country on oil rates, which are imposing a negative impact on the growth rate, but these are expected to be overcome in near future by government efforts.

This report also provides extensive information and rational analysis on the Saudi Arabian healthcare market as well as on the facts like increasing number of health insurance. Thus, it provides valuable information to pharmaceutical & healthcare companies and investors looking to enter this market. Analysis and statistics regarding market size, growth, share, regulatory environment and trends in technology development have been thoroughly analyzed in the report to present a comprehensive overview of the market to clients.

Contents

• 1. Analyst View
• 2. Saudi Arabia Healthcare Market Attractions
  • 2.1 Rapidly Growing Population
  • 2.2 Increasing Prevalence of Chronic Diseases
  • 2.3 Booming Economy
  • 2.4 Strong Government Support
• 3. Macroeconomic and Healthcare Profile
  • 3.1 Macroeconomic Indicators
  • 3.2 Demographics and Major Healthcare Indicators
  • 3.3 Healthcare Spending and Financing
• 4. Hospital Services Market
  • 4.1 Hospital and Bed Capacity
    • 4.1.1 MOH Hospitals
    • 4.1.2 Other Government Hospitals
    • 4.1.3 Private Hospitals
  • 4.2 Inpatients and Outpatients
  • 4.3 Hospital Occupancy and Average Length of Stay
  • 4.4 Hospital Health Force
  • 4.5 Hospital Beds Demand Projection (2010-2012)
  • 4.6 Investment and Infrastructure Projection (2010-2012)
• 5. Pharmaceutical Market
  • 5.1 Market Trend Analysis
  • 5.2 Imports and Domestic Production
  • 5.3 Leading Players
  • 5.4 Leading Drugs
    • 5.4.1 Future Outlook (2010-2012)
• 6. Medical Devices Market
  • 6.1 Market Trend Analysis
  • 6.2 Imports and Domestic Production
  • 6.3 Market Segmentation
    • 6.3.1 Future Outlook (2010-2012)
• 7. Government Initiatives
  • 7.1 Healthcare Education
  • 7.2 Mandatory Health Insurance
  • 7.3 Private Sector Reforms
• 8. Industry Road Blocks
  • 8.1 Fluctuating Oil Prices
  • 8.2 Staff Shortage
  • 8.3 Bureaucracy and Reform Delays
  • 8.4 Medical Tourism
• List of Figures:
  • Figure 2-1: Population (Million), 2006, 2008 & 2012
  • Figure 2-2: Population Aged 65 Years and Above ('000), 2006, 2008 & 2012
  • Figure 2-3: Prevalence of Diabetes in Age Group 20-79 Years (%), 2007 & 2025
  • Figure 2-4: Relative Cost per Person by Number of Chronic Conditions
  • Figure 2-5: Nominal GDP (Billion US$), 2006, 2008 & 2012
  • Figure 3-1: Leading Causes of Death (%), 2005
  • Figure 3-2: Forecast for Leading Causes of Death (%), 2030
  • Figure 3-3: Sources of Healthcare Financing (%), 2005
  • Figure 4-1: Number of Hospital Beds (2005-2009)
  • Figure 4-2: Hospital Beds by Institution (%), 2007
  • Figure 4-3: Hospitals by Institution (%), 2007
  • Figure 4-4: Inpatient Admission Rate and Average Length of Stays in Selected Countries
  • Figure 4-5: Health Workers by Nationality (%), 2007
  • Figure 4-6: Forecast for Number of Hospital Beds (2010-2012)
  • Figure 4-7: Forecast for Hospital Beds by Institution (%), 2012
  • Figure 4-8: Budget Allocated for Healthcare and Social Services (Billion SAR), 2008 & 2009
  • Figure 4-9: Share of Healthcare and Social Services in Budget Allocation (2009)
  • Figure 4-10: Investment for Increasing Hospital Bed Capacity (Million SAR), 2008-2012
  • Figure 4-11: Forecast for Requirement of Additional Healthcare Floor Space (Million Square Foot), 2012
  • Figure 5-1: Pharmaceutical Market (Billion SAR), 2006-2009
  • Figure 5-2: Imports and Domestically Manufactured Drugs in Pharmaceutical Market (Billion SAR), 2006-2009
  • Figure 5-3: Share of Imports and Domestically Manufactured Drugs in Pharmaceutical Market (2006-2009)
  • Figure 5-4: Pharmaceutical Imports by Region (%), 2006
  • Figure 5-5: Share of International and Domestic Players in Pharmaceutical Market by Sales Value (Q3 2007)
  • Figure 5-6: Forecast for Pharmaceutical Market (Billion SAR), 2010-2012
  • Figure 6-1: Medical Devices Market (Million US$), 2006-2009
  • Figure 6-2: Share of Imported and Domestically Manufactured Devices in Medical Devices Market (2006)
  • Figure 6-3: Medical Equipment Imports by Major Categories (%), 2006
  • Figure 6-4: Medical Supplies Imports by Major Categories (%), 2006
  • Figure 6-5: Forecast for Medical Devices Market (Million US$), 2010-2012
  • Figure 7-1: Health Insurance Premium (Billion SAR), 2008-2012
• List of Tables:
  • Table 2-1: Population Growth Rates in Major Countries (%), 2000 to 2015
  • Table 2-2: Prevalence of Overweight and Obesity in Males and Females (%), 2005 & 2015
  • Table 3-1: Key Macroeconomic Indicators (2006-2009)
  • Table 3-2: Forecast for Key Macroeconomic Indicators (2010-2012)
  • Table 3-3: Key Demographic and Healthcare Indicators (2006-2009)
  • Table 3-4: Forecast for Key Demographic and Healthcare Indicators (2010-2012)
  • Table 3-5: Leading Causes of Death (Numbers), 2005
  • Table 3-6: Forecast for Leading Causes of Death (Numbers), 2030
  • Table 3-7: Healthcare Spending Statistics (2006-2009)
  • Table 3-8: Forecast for Healthcare Spending Statistics (2010-2012)
  • Table 4-1: Number of Hospitals and Beds by Institution (2005 & 2007)
  • Table 4-2: Hospital Beds Ratio of Selected Countries (per '000 Population)
  • Table 4-3: Number of MOH Hospitals by Specialty (2007)
  • Table 4-4: Number of MOH Hospital Beds by Specialty (2007)
  • Table 4-5: Number of Other Government Hospital Beds by Specialty (2007)
  • Table 4-6: Private Healthcare Facilities by Type (Numbers), 2007
  • Table 4-7: Number of Private Hospital Beds by Specialty (2007)
  • Table 4-8: Number of Private Clinics by Specialty (2007)
  • Table 4-9: Number of Inpatients by Institution (2003 & 2007)
  • Table 4-10: Number of Outpatient Visits by Institution (2003 & 2007)
  • Table 4-11: Number of Physicians by Institution (2003 & 2007)
  • Table 4-12: Number of Nurses by Institution (2003 & 2007)
  • Table 4-13: Number of Allied Health Workers by Institution (2003 & 2007)
  • Table 5-1: Share of Top Ten Players in Pharmaceutical Market by Sales Value (Q3 2007)
  • Table 5-2: Share among Domestic Players in Pharmaceutical Market by Sales Value (Q3 2007)
  • Table 5-3: Share of Top Ten Drugs in Pharmaceutical Market by Sales Value (Q3 2007)
  • Table 5-4: Share of Top Ten Drugs in Pharmaceutical Market by Sales Volume (Q3 2007)